Perspectives: Pelosi’s Aggressive Drug Pricing Plan Doesn’t Even Have To Pass To Scare Pharma
Read recent commentaries about drug-cost issues.
Archives: Morning Breakouts
24,321-24,340 of 113,179 results
-
-
Trump Touts Progress Of His ‘Ambitious Campaign’ To Curb Drug Prices, But Most Of It Hasn’t Even Been Implemented
News outlets report on stories related to pharmaceutical pricing.
By brilabuskes -
Viewpoints: Ban Candy-Flavored E-Cigs To Protect Children From Dangers Of Big Tobacco; Lessons On Taking Care Of Refugees In Border Camps
Opinion writers weigh in on these health topics and others.
By janicelkff -
State Highlights: Florida Judge Rules 4-Year-Old Boy Stays With Grandparents After Parents Stop His Chemo; Former USC Doctor Charged With Sex Abuse Surrenders License
Media outlets report on news from Florida, California, Ohio, Missouri, Kansas, Wisconsin, Arizona, New Jersey, Texas and Massachusetts.
By brilabuskes -
Different Takes: Stop Making Excuses, Senators, And Do Something About Gun Control; No, Really, Background Checks Might Work
Opinion writers weigh in on how to stop mass shootings in the U.S.
By janicelkff -
Men Do Get Breast Cancer, But There’s Little Research To Show What Treatments Are Safe, Effective
Often times it's women who get cut out of clinical trials for innovative drugs, but when it comes to breast cancer it's men who are getting the short shrift. In other public health news: obesity, malaria, snacking, the siblings of sick kids, and a fungal disease.
By brilabuskes -
Depression Drug Spravato Reduces Symptoms In 24 Hours For People Considering Suicide, Studies Find
The trials, done by the drug's maker Johnson & Johnson, might yield important treatment information for severely depressed patients because other treatments can take weeks to go into effect. Mental health news looks at suicide rates, telemedicine, positive relationships early in life, and first responders, as well.
By brilabuskes -
FDA Defends Framework As It Dismisses Advocacy Group’s Petition To Put Moratorium On Opioid Approvals
Public Citizen says the agency displayed “dangerously deficient oversight” when it approved opioids during a growing crisis. The FDA denied the request for a moratorium, pointing to the framework and guidance it has developed in the years since. In addition, the FDA argued that it is not permitted under federal law to impose a moratorium on approving new medicines. In other news: a judge knocks down Purdue Pharma's efforts to dismiss public nuisance claims and the AMA is urging states to be proactive on opioid abuse treatment.
By brilabuskes -
Abortion Landscape In Texas Offers Look At What Future Holds For States As They Add More Restrictions
"I've been telling folks, if you want to see the future, we've been living that since 2012," said Denise Rodriguez of the Dallas-based Texas Equal Access Fund. Many women in the state need at least two days to obtain the procedure with just how far they have to drive to their nearest clinic. Meanwhile, Planned Parenthood has announced that due to lack of state and federal funding, two of its Ohio clinics will be closing later this month.
By brilabuskes -
Protesters Swarm Calif. Capitol In Last-Ditch Effort To Stop Governor From Signing Controversial Vaccination Bill
But despite some 11th-hour hesitations over the past week, Gov. Gavin Newsom signed the legislation cracking down on medical exemptions into law. Protesters forced delays in both the Assembly and Senate. They unfurled an upside-down American flag from the Senate's public gallery in a traditional signal of distress and chanted "My kids, my choice" and "We will not comply."
By brilabuskes -
FDA Candidate’s Track Record Of Emerging From High-Profile Scandals Unscathed Highlights Political Savvy, Backers Say
Dr. Stephen Hahn, one of the frontrunners for the top FDA position, has been in the middle and on the fringes of multiple high-profile controversies throughout his career. But what they've revealed is a knack for operating within highly rigid and institutionalized environments, his supporters say.
By brilabuskes -
A Look Back At Bernie Sanders’ Early Political Career–And A Significant Death–Shows Why He Stakes His Legacy On ‘Medicare For All’
Decades before "Medicare for All" became the buzzword du jour for the elections, Sen. Bernie Sanders, frustrated with how his family struggled to pay for his mother's care when she was dying, made a trip to Canada. He walked away from that "thrilled" with the prospect of something better than the U.S. health care system. Meanwhile, where do the candidates stand on the proposal? Reuters takes a look ahead of the Democratic debate this week.
By brilabuskes -
Pelosi’s Aggressive Drug Plan Would Allow Medicare To Negotiate Prices For 250 Meds And Then Set Commercial Cost
House Speaker Nancy Pelosi's long-awaited plan to reduce drug prices is far more ambitious than what was expected, and experts say that reveals an attitude on the Hill that a serious bipartisan proposal is not in the cards for this particular Congress.
By brilabuskes -
Playing Both Sides? Corporations Straddle Lines Of Gun Debate With Open-Carry Requests
The decision by Walmart and other stores to "request" that their customers don't openly carry weapons into the stores is being lauded by gun control activists. But legal experts say they could go further and haven't. Meanwhile, psychologists are alarmed that sources say the White House is considering a controversial plan that would utilize technology to prevent mass shootings. And polls show that, political narrative aside, Republican voters want tighter gun laws, too.
By brilabuskes -
Juul Issued Warning From FDA For Illegally Marketing Vaping Products As Less Harmful Alternative To Cigarettes
“Regardless of where products like e-cigarettes fall on the continuum of tobacco product risk, the law is clear that, before marketing tobacco products for reduced risk, companies must demonstrate with scientific evidence that their specific product does in fact pose less risk or is less harmful,” said acting FDA Commissioner Ned Sharpless. The public rebuke came amid a burgeoning epidemic of vaping-related lung illnesses across the country.
By brilabuskes -
First Edition: September 10, 2019
Today's early morning highlights from the major news organizations.
By brilabuskes -
Viewpoints: Big Tobacco Turns To Vaping To Profit Off The Pain, Suffering Of Millions; Medicare Advantage Transforms A Dysfunctional Insurance Market
Opinion writers weigh in on these health issues and others.
By janicelkff -
Following Tumultuous Week, Governor And California Lawmaker Reach Agreement On Vaccination Bill
Some of the amendments sought by Gov. Gavin Newsom at the 11th hour would significantly weaken the bill, authored by state Sen. Richard Pan, but other changes would bring new scrutiny to exemptions written by doctors who have faced disciplinary action. The changes would include Newsom's proposal to grandfather in all existing medical exemptions before Jan. 1.
By brilabuskes -
State Highlights: Street Medicine Team In Atlanta Hits Roads, Bridges To Find Homeless; Nonprofit Helps Underserved Patients ‘Across Whole U.S.’ Not Just Appalachia
Media outlets report on news from Georgia, Maryland, Missouri, California, Minnesota, Ohio, Wisconsin, Arizona, Oregon, Texas and Massachusetts.
By brilabuskes -
As Abortion Restrictions Tighten In Red Areas Across Country, Women Are Crossing State Lines To Seek Care
Nationwide, women who traveled from another state received at least 44,860 abortions in 2017, the most recent year available, according to an Associated Press analysis of data from 41 states. Thirteen states saw a rise in the number of out-of-state women having abortions between 2012 and 2017.
By brilabuskes